Following the Commission’s proposal to strengthen cancer prevention through early detection, the Council of the European Union has adopted a new approach on cancer screening. This is an important step to improve early detection throughout the EU, an important goal of the Europe’s Beating Cancer Plan. As announced in September, this new EU approach, based on the latest […]
Read More
Evolution of monkeypox in Europe
Monkeypox (MPX) is a zoonotic disease and is currently the most prevalent orthopoxviral infection in humans after the eradication of smallpox and the cessation of universal smallpox vaccination. In endemic areas, monkeypox virus (MPXV) probably circulates among a number of mammals, although there is no known reservoir. Occasional spill-over events to humans generate outbreaks. MPXV […]
Read MoreEvolución de la viruela del mono en Europa
La viruela del mono (MPX) es una enfermedad zoonótica y actualmente es la infección ortopoxviral más prevalente en el ser humano tras la erradicación de la viruela y el cese de la vacunación universal contra la viruela. En las zonas endémicas, el virus de la viruela del mono (MPXV) circula probablemente entre varios mamíferos, aunque […]
Read More
EU Global Health Strategy
The Commission adopted a new EU Global Health Strategy to improve global health security and deliver better health for all in a changing world. With the Strategy, the EU deepens its leadership and reasserts its responsibility for tackling key global challenges and health inequalities head-on: the unfinished agenda in global health and combatting health threats […]
Read More
HERA secures up to 2 million doses of the monkeypox vaccine
The Commission’s Health Preparedness and Response Authority (HERA), has signed a Joint Procurement Framework contract with the company Bavarian Nordic, for the supply of up to 2 million doses of the monkeypox vaccine in the course of 2023 and 2024. This offers 14 participating countries the possibility to purchase doses to address their medium- and […]
Read More
High monkeypox vaccine acceptance among male users of smartphone-based online gay-dating apps in Europe
Male adult users of smartphone-based online gay dating apps in the European region have high acceptance of monkeypox (MPX) vaccination. At the same time, there are specific groups with a high degree of vaccine hesitancy to whom campaigns should be tailored. Here, public health providers together with community-based organisations play an important role. This is […]
Read More
New Omicron sub-lineage likely to cause further increase in covid-19 cases
At least five EU/EEA countries have detected the circulation of the SARS-CoV-2 variant sub-lineage BQ.1 during week 40, 2022. ECDC modelling forecasts predict that BQ1 and its sub-lineage BQ1.1 will become the dominant SARS-CoV2 strains in EU/EEA by mid-November to the beginning of December 2022. This will likely contribute to an increase in the number […]
Read More
Monkeypox: Commission purchases treatment courses
The Commission has secured over 10,000 treatment courses of tecovirimat to treat Monkeypox. This emergency procurement is funded by the Health Emergency Preparedness and Response Authority (HERA) and channelled via rescEU to treat patients in Member States with immediate needs. Tecovirimat is produced by the pharmaceutical company Meridian/SIGA. Stella Kyriakides, Commissioner for Health and Food Safety, said: “Today, with our […]
Read More
European Health Union: cancer screening
As part of the EU Cancer Screening Scheme to be put forward under Europe’s Beating Cancer Plan, the Commission presents a new approach to support Member States increasing the uptake of cancer screening. Focusing on detection of cancers at an early stage, the objective of the proposed recommendation is to increase the number of screenings, covering […]
Read More